Psychosocial functioning and quality of life in body dysmorphic disorder

Comprehensive Psychiatry

Volumn 46, Issue 4, 2005, Pages 254-260

  Phillips, Katharine A ^a,b   Menard, William ^a   Fay, Christina ^a   Pagano, Maria E ^b  

^a BUTLER HOSPITAL   (United States)

^b BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BODY DYSMORPHIC DISORDER; COMMUNITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PSYCHIATRIC TREATMENT; PUBLICATION; QUALITY OF LIFE; RELIABILITY; SCORING SYSTEM; SELF REPORT; SHORT FORM 36; SOCIAL ADAPTATION; SOCIAL PSYCHOLOGY; UNITED STATES;

ADOLESCENT; ADULT; COGNITIVE THERAPY; CULTURE; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PATIENT SATISFACTION; PSYCHOLOGY; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SOCIAL ADJUSTMENT; SOMATOFORM DISORDERS;

EID: 20444476765     PISSN: 0010440X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.comppsych.2004.10.004     Document Type: Article

References (34)

1. O.J. Bienvenu, J.F. Samuels, M.A. Riddle, R. Hoehn-Saric, K.Y. Liang, and B.A. Cullen The relationship of obsessive-compulsive disorder to possible spectrum disorders: results from a family study Biol. Psychiatry 48 2000 287 293
2. J.E. Grant, S.W. Kim, and S.J. Crow Prevalence and clinical features of body dysmorphic disorder in adolescent and psychiatric inpatients J. Clin. Psychiatry 62 2001 517 522
3. K.A. Phillips, and S. Diaz Gender differences in body dysmorphic disorder J. Nerv. Ment. Dis. 185 1997 570 577
4. D. Veale, A. Boocock, K. Gournay, W. Dryden, F. Shah, and R. Willson Body dysmorphic disorder: a survey of fifty cases Br. J. Psychiatry 169 1996 196 201
5. E. Hollander, A. Allen, J. Kwon, B. Aronowitz, J. Schmeidler, and C. Wong Clomipramine vs desipramine crossover trial in body dysmorphic disorder: selective efficacy of a serotonin reuptake inhibitor in imagined ugliness Arch. Gen. Psychiatry 56 1999 1033 1039
6. F.R. Schneier, L.R. Heckelman, R. Garfinkel, R. Campeas, B.A. Fallon, and A. Gitow Functional impairment in social phobia J. Clin. Psychiatry 55 1994 322 332
7. L.M. DeMarco, L.C. Li, K.A. Phillips, and S.L. McElroy Perceived stress in body dysmorphic disorder J. Nerv. Ment. Dis. 186 1998 724 726
8. K.A. Phillips Quality of life for patients with body dysmorphic disorder J. Nerv. Ment. Dis. 188 2000 170 175
9. J.E. Ware Jr. SF-36 health survey manual and interpretation guide 1993 The Health Institute, New England Medical Center Boston
10. C.A. McHorney, J.E. Ware Jr., and A.E. Raczek The MOS 36-item short-form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med. Care 31 1993 247 263
11. K.A. Phillips, R.S. Albertini, and S.A. Rasmussen A randomized placebo-controlled trial of fluoxetine in body dysmorphic disorder Arch. Gen. Psychiatry 59 2002 381 388
12. K.A. Phillips, and F. Najjar An open-label study of citalopram in body dysmorphic disorder J. Clin. Psychiatry 64 2003 715 720
13. K.A. Phillips, and S.A. Rasmussen Change in psychosocial functioning and quality of life in body dysmorphic disorder with fluoxetine versus placebo Psychosomatics 45 2004 438 444
14. A.C. Leon, D.A. Solomon, T.I. Mueller, C.L. Turvey, J. Endicott, and M.B. Keller The Range of Impaired Functioning Tool (LIFE-RIFT): a brief measure of functional impairment Psychol. Med. 29 1999 869 878
15. A.A. Nierenberg, K.A. Phillips, T.J. Petersen, K.E. Kelly, J.E. Alpert, and J.J. Worthington Body dysmorphic disorder in outpatients with major depression J. Affect. Disord. 69 2002 141 148
16. M.M. Weissman, B.A. Prusoff, D.W. Thompson, P.S. Harding, and J.K. Myers Social adjustment by self-report in a community sample and in psychiatric outpatients J. Nerv. Ment. Dis. 166 1978 317 326
17. J. Endicott, J. Nee, W. Harrison, and R. Blumenthal Quality of life Enjoyment and Satisfaction Questionnaire: a new measure Psychopharmacol. Bull. 29 1993 321 326
18. M.H. Rapaport, J. Endicott, and C.M. Clary Posttraumatic stress disorder and quality of life: results across 64 weeks of sertraline treatment J. Clin. Psychiatry 63 2002 59 65
19. Rapaport MH, Clary C, Fayyed R, Endicott J. Quality of life impairment in depressive and anxiety disorders. Am J Psychiatry [in press].
20. American Psychiatric Association DSM-IV: diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Press, Inc Washington (DC)
21. K.A. Phillips, E. Hollander, S.A. Rasmussen, B.R. Aronowitz, C. DeCaria, and W.K. Goodman A severity rating scale for body dysmorphic disorder: development, reliability, and validity of a modified version of the Yale-Brown Obsessive-Compulsive Scale Psychopharmacol. Bull. 33 1997 17 22
22. J.L. Eisen, K.A. Phillips, L. Baer, D.A. Beer, K.D. Atala, and S.A. Rasmussen The Brown Assessment of Beliefs Scale: reliability and validity Am. J. Psychiatry 155 1998 102 108
23. J. Cohen Statistical power analysis for the behavioral sciences 2nd ed. 1988 Academic Press New York
24. L.M. Koran, M.L. Thienemann, and R. Davenport Quality of life for patients with obsessive-compulsive disorder Am. J. Psychiatry 153 1996 783 788
25. D.A. Revicki, M. Tohen, L. Gyulai, C. Thompson, S. Pike, and A. Davis-Vogel Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder Harv. Rev. Psychiatry 5 1997 75 81
26. J. Russo, C.A. Trujillo, D. Wingerson, K. Decker, R. Ries, and H. Wetzler The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients Med. Care 36 1998 752 756
27. J.L. Wetherell, B.W. Palmer, S.R. Thorp, T.L. Patterson, S. Golshan, and D.V. Jeste Anxiety symptoms and quality of life in middle-aged and older outpatients with schizophrenia and schizoaffective disorder J. Clin. Psychiatry 64 2003 1476 1482
28. F. Neziroglu, and S. Khemlani-Patel A review of cognitive and behavioral treatment for body dysmorphic disorder CNS Spectr. 7 2002 464 471
29. K.A. Phillips Pharmacologic treatment of body dysmorphic disorder: review of the evidence and a recommended treatment approach CNS Spectr. 7 2002 453 460
30. K.A. Phillips, M.E. Pagano, C. Fay, and W. Menard Pharmacotherapy received by individuals with body dysmorphic disorder [Abstracts] National Institute of Mental Health NCDEU 44th Annual Meeting. Phoenix, AZ 2004 229
31. A.C. Leon, M.B. Keller, M.G. Warshaw, T.I. Mueller, D.A. Solomon, and W. Coryell Prospective study of fluoxetine treatment and suicidal behavior in affectively ill subjects Am. J. Psychiatry 156 1999 195 201
32. M.G. Warshaw, and M.B. Keller The relationship between fluoxetine use and suicidal behavior in 654 subjects with anxiety disorders J. Clin. Psychiatry 57 1996 158 166
33. J.A. Cotterill Body dysmorphic disorder Dermatol. Clin. 14 1996 457 463
34. K.A. Phillips, J. Grant, J. Siniscalchi, and R.S. Albertini Surgical and nonpsychiatric medical treatment of patients with body dysmorphic disorder Psychosomatics 42 2001 504 510